1. Home
  2. ADAG vs FNGR Comparison

ADAG vs FNGR Comparison

Compare ADAG & FNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • FNGR
  • Stock Information
  • Founded
  • ADAG 2011
  • FNGR 2016
  • Country
  • ADAG China
  • FNGR Singapore
  • Employees
  • ADAG N/A
  • FNGR N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • FNGR Computer Software: Prepackaged Software
  • Sector
  • ADAG Health Care
  • FNGR Technology
  • Exchange
  • ADAG Nasdaq
  • FNGR Nasdaq
  • Market Cap
  • ADAG 95.6M
  • FNGR 108.1M
  • IPO Year
  • ADAG 2021
  • FNGR N/A
  • Fundamental
  • Price
  • ADAG $2.14
  • FNGR $1.96
  • Analyst Decision
  • ADAG Strong Buy
  • FNGR
  • Analyst Count
  • ADAG 1
  • FNGR 0
  • Target Price
  • ADAG $5.00
  • FNGR N/A
  • AVG Volume (30 Days)
  • ADAG 73.9K
  • FNGR 174.9K
  • Earning Date
  • ADAG 07-25-2024
  • FNGR 10-15-2024
  • Dividend Yield
  • ADAG N/A
  • FNGR N/A
  • EPS Growth
  • ADAG N/A
  • FNGR N/A
  • EPS
  • ADAG N/A
  • FNGR N/A
  • Revenue
  • ADAG $815,746.00
  • FNGR $31,176,174.00
  • Revenue This Year
  • ADAG N/A
  • FNGR $260.03
  • Revenue Next Year
  • ADAG $2.70
  • FNGR N/A
  • P/E Ratio
  • ADAG N/A
  • FNGR N/A
  • Revenue Growth
  • ADAG N/A
  • FNGR N/A
  • 52 Week Low
  • ADAG $1.34
  • FNGR $1.63
  • 52 Week High
  • ADAG $4.38
  • FNGR $4.70
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 37.47
  • FNGR 46.12
  • Support Level
  • ADAG $2.20
  • FNGR $1.79
  • Resistance Level
  • ADAG $3.14
  • FNGR $2.39
  • Average True Range (ATR)
  • ADAG 0.30
  • FNGR 0.14
  • MACD
  • ADAG -0.09
  • FNGR 0.01
  • Stochastic Oscillator
  • ADAG 18.63
  • FNGR 28.33

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company business line includes Telecommunications Products and Services; Value Added Products and Services; Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Big Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.

Share on Social Networks: